Delivery Order SPE2D021DA002-SPE2D324F013W
- Not listed
- This federal contract award, valued at $1,381.17, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for the supply of ISENTRESS 400 MG TABLET, with a period of performance through June 21, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
- This is a $1,381.17 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ISENTRESS 400 mg tablets, with a period of performance through May 17, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which...
- This federal contract award, valued at $1,381.17, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4566483326 - ISENTRESS 400 MG TABLET, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
- This federal contract award, valued at $17,955.21, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under the DLA's Medical Supply Chain program and does not have a set-aside designation. The award is for the delivery of ISENTRESS 400 MG TABLET, a prescription pharmaceutical product, with an ultimate completion date of May 3, 2024. This contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,668.19 firm fixed-price delivery order is for the supply of ISENTRESS 400 MG TABLET, a prescription medication, to fulfill the recurring pharmaceutical needs of military health facilities. The award is part of a larger $499,999,999 indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $6,905.85, is for the delivery of ISENTRESS 400 mg tablets. The contract has a period of performance through June 3, 2024 and uses a Firm Fixed Price pricing structure. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that provides a range of pharmaceutical products and medical supplies to the Department of Defense...
- This federal contract award, valued at $13,811.70, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Isentress 400 mg tablets, with a completion date of June 25, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- This federal contract award was granted to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,524.68 firm fixed-price delivery order contract is for the supply of ISENTRESS 400 MG TABLET to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. This contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA valued up to $499,999,999, which allows the agency...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $11,587.21. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to provide a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military...
- The federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,381.17 firm fixed-price delivery order is for ISENTRESS 400 MG TABLET and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D324F013WDelivery Order
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The single-award indefinite delivery contract (IDC) is valued at up to $499,999,999 and runs through December 31, 2025. This contract vehicle allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The specific award referenced in the information provided is a delivery order under the IDC for 4564701240 ISENTRESS 400 MG TABLET, with a ceiling value of $1,381.17 and a completion date of May 24, 2024. This pharmaceutical product delivery order does not have a set-aside designation. Through this contract, DMS Pharmaceutical Group supplies a vast array of medications, including common and specialized pharmaceutical products, to support the diverse medical needs of military personnel and their dependents across various Department of Defense (DoD) healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 5/23/24 |